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INTRODUCTION
Acute severe pancreatitis manifests itself as a sudden and im-
portant occurrence with a rapid deterioration of hopes [1]. As-
cites-peritonitis in acute pancreatitis are quite common results of 
the early period of action[2]. During the first week of acute severe 
pancreatitis, in most cases death occurs as a result of multiple 
organ failure, in the following weeks, the infection plays a more 
important role [3]. Tang J.C.F. [3] recommends identifying pa-
tients with acute pancreatitis who are most in need of aggressive 
medical care, differentiating the severity of their disease. 
Severity prediction is a valuable tool in the clinic, but in 
order to increase clinical benefit, it must anticipate real severity 
factors – (peri) pancreatic necrosis and / or organ failure [4]. 
Identification of early markers is important because there is a 
concern, especially among resuscitators, that patients are often 
hospitalized in the intensive care unit too late [5].
In the article “Predicting the prognosis of acute pancreatitis” 
C. Forsmark, D. Yadav [6] point to the need to identify the best 
biological markers of the main factors that determine the out-
come – organ failure and pancreatic necrosis, as well as factors 
related to with the development of severe systemic inflammatory 
response to pancreatic necrosis as well as factors of the patient’s 
body associated with development severe systemic inflammatory 
response to pancreatic necrosis. This approach can help in under-
standing the mechanisms of severe disease, identifying patients 
at risk shortly after or before damage to pancreatic tissue, and 
developing treatments to reduce the severity of the disease [6].
Procalcitonin is an inactive 116-amino acid propeptide of 
the biologically active hormone calcitonin, which, as first 
described, is characterized by significant concentrations in 
patients with bacterial and fungal infections [7].
According to the recommendations of WSES 2019, the 
level of procalcitonin 3.8 ng / ml and above 96 hours after 
the onset of the disease indicates pancreatic necrosis with 
a sensitivity of 93% and a specificity of 79% [8,9]. 
Antibiotics are always recommended for the treatment of 
infected severe acute pancreatitis. However, the diagnosis 
of infected pancreatitis is difficult because the clinical pic-
ture is no different from the inflammatory reaction caused 
by pancreatitis itself. The timing of infection in pancreatic 
necrosis is variable and unpredictable, although their peak 
is observed mainly from the second to the fourth week from 
the onset of the disease. Clinical signs are characterized by 
high sensitivity, but insufficient specificity [10,11].
Procalcitonin is a promising serological marker of pan-
creatic infection, especially pancreatic infection in combi-
nation with organ failure [12]. Specificity for procalcitonin 
in the meta-analysis ranging from 83 to 91% [13,14].
THE AIM 
The aim of the study was to analyze the prognostic poten-
tial of procalcitonin in acute pancreatitis complicated by 
ascites-peritonitis.
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the study group depending on the presence of elevated concentrations of procalcitonin or its absence at the time of hospitalization, a significant difference was found (p <0.05).
Conclusions: In our opinion, the use of procalcitonin as a predictor of infectious complications in the dynamics of the disease will determine the category of patients in whom 
reducing the risk of flora translocation through the use of early oral antibiotic prophylaxis and parenteral drugs tropic to pancreatic tissue may reduce the incidence of purulent 
complications. In another category of patients, antibacterial therapy is not advisable due to the low risk of purulent-septic complications.
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MATERIALS AND METHODS 
The study analyzed the results of a comprehensive exam-
ination and treatment of 18 patients with acute pancreatitis 
complicated by enzymatic ascites-peritonitis, including 13 
patients who were treated in the surgical department of KP 
“Poltava Regional Clinical Hospital. MV Sklifosovsky POR 
“, and 5 patients of other emergency hospitals in Poltava, 
in the period from 2017 to 2019.
In addition to standard screening methods, these patients 
were additionally tested for procalcitonin to predict an 
adverse course in the early period.
Statistical analysis of the study materials was performed 
using the program “STATISTICA 10.0” (StatSoft, Inc., 
USA) by methods of descriptive statistics with the calcula-
tion in the studied groups of quality indicators in the form 
of frequencies and their percentages.
The statistical significance of differences was determined 
by a nonparametric method between the indicators of inde-
pendent groups using Fisher’s exact criterion. Differences 
at p <0.05 were considered statistically significant for all 
types of analysis.
This set of statistical methods for evaluating the results 
of treatment allowed to obtain evidence-based results.
RESULTS AND DISCUSSION
We studied the level of procalcitonin during hospitalization 
and after 72 hours in patients with acute pancreatitis com-
plicated by ascites-peritonitis. Enzyme-linked immunosor-
bent assays were performed on the basis of the Research 
Institute of Genetic and Immunological Foundations of 
Pathology and Pharmacogenetics “UMSA”, Poltava. The 
level of procalcitonin was determined using a test system: 
“A set of reagents for enzyme-linked immunosorbent assay 
of procalcitonin concentration in human serum (plasma)” 
Procalcitonin-IFA-BEST “, VECTOR-BEST, Russia”.
In patients of the study group, the values  of procalcitonin 
at the time of hospitalization and after 72 h were distributed 
as follows (Table I).
To assess the relationship between the presence of ele-
vated procalcitonin levels at the time of hospitalization of 
0.5 ng / ml and above and unsatisfactory treatment results, 
differences were assessed using an accurate Fisher test.
The following indicators were selected as criteria and 
target points for the analysis of disease dynamics:
1. Organ dysfunction after 72 hours
2.  Development of infectious complications in the dynam-
ics of the disease.
3. Mortality (Table II).
When comparing differences in the development of long-
term organ dysfunction and mortality in patients of the 
study group depending on the presence of elevated concen-
trations of procalcitonin or its absence at the time of hos-
pitalization, no significant difference was found (p> 0.05).
When comparing differences in the development of 
infectious complications in the dynamics of the disease 
in patients of the study group depending on the presence 
of elevated concentrations of procalcitonin or its absence 
at the time of hospitalization, a significant difference was 
found (p <0.05).
According to the recommendations of WSES 2019, the 
level of procalcitonin 3.8 ng / ml and above 96 hours after 
the onset of the disease indicates pancreatic necrosis with 
a sensitivity of 93% and a specificity of 79% [8,9].  At the 
time of hospitalization, at the time of hospitalization and 
after 72 hours in patients of the study group, the concentra-
tion of procalcitonin did not exceed 3.8 ng / ml. However, 
procalcitonin is recognized as an effective predictor of the 
severity of acute pancreatitis and the risk of developing 
infected pancreatitis [7]. A number of studies demonstrate 
the effectiveness of determining the serum concentration of 
procalcitonin in predicting the risk of infected pancreatic 
necrosis [13,15–17]. Therefore, in predicting the course of 
pancreatitis, the following indicators are important:
•  0.5 ng / ml during hospitalization and maintaining the 
level of increase in the dynamics;
•  above 2.0 ng / ml is traditionally interpreted as a high risk 
of need for surgery for infectious complications;
•  ng / ml 96 hours after the onset of the disease indicates 
infected pancreatic necrosis.
Values  of procalcitonin concentration of 0.5 ng / ml and 
more are interpreted as pathological and can be used to 
predict the severity of acute pancreatitis and the develop-
ment of infected pancreatic necrosis in the dynamics of 
the disease [13].
The obtained results suggest that the change in treatment 
tactics in patients with acute severe pancreatitis compli-
cated by ascites-peritonitis who have elevated procalci-
Table I. Procalcitonin level at the time of hospitalization and after 72 hours.
Procalcitonin level  
(ng / ml)
at the time of 
hospitalization after 72 hours 
Abs. % Abs. %
<0,1 2 11 1 6
0,1-0,4 9 50 11 61
0,5-2 4 22 4 22
2,1-10 3 17 2 11
>10 0 0 0 0
Table II. Differences in the presence of unsatisfactory treatment results 
depending on the presence or absence of elevated concentrations of 




of 0.5 ng / ml and above р
Missing Available 
Abs. % Abs. %
Death 1 6 3 17 0,093
Organ dysfunction  
after 72 hours 3 17 5 28 0,066
Development of 
infectious complications 1 6 6 33 0,005
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tonin levels (> 0.5 ng / ml) at the time of hospitalization 
and maintenance / increase of its level in the dynamics 
at re-examination after 72 h may help reduce the risk of 
purulent-septic complications.
CONCLUSIONS
In our opinion, the use of procalcitonin as a predictor of 
infectious complications in the dynamics of the disease will 
determine the category of patients whose risk of translo-
cation of flora is reduced by the use of early oral antibiotic 
prophylaxis and parenteral drugs tropic to pancreatic tis-
sues may reduce the incidence of purulent complications. 
In another category of patients, antibacterial therapy is 
not advisable due to the low risk of purulent-septic com-
plications.
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